From: A pilot trial of human amniotic fluid for the treatment of COVID-19
Variable | n |
---|---|
Age (mean, range) | 52, 24–76 |
Female sex | 4 |
Weight (kg; mean, range) | 91 (42–140) |
Race/Ethnicity | |
White | 5 |
American Indian/Alaskan Native | 2 |
Hispanic | 2 |
Unknown/other | 1 |
Medical History | Â |
Anemia | 1 |
Coronary artery disease | 1 |
Diabetes | 6 |
Elevated liver enzymes | 1 |
Heart murmur | 1 |
Hyperlipidemia | 2 |
Hypertension | 5 |
Liver disease | 1 |
Mitral valve disease | 1 |
Respiratory disease (e.g., asthma) | 2 |
No past medical history | 2 |